Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Goldstein

Showing results (21-30 of 291) with videos related to

Pageof 30
Sort By:
Handbook of Clinical Neurology|October 8, 2013
Sympathetic neuroimagingDavid S Goldstein
Heart Rhythm|December 14, 2020
The possible association between COVID-19 and postural tachycardia syndromeDavid S Goldstein
JACC. Cardiovascular Imaging|November 14, 2016
Cardiac Dysautonomia and Survival in Hereditary Transthyretin AmyloidosisDavid S Goldstein
Movement Disorders Clinical Practice|July 6, 2026
Cardiac Sympathetic Neuroimaging in Autonomic Synucleinopathies: <sup>123</sup>I-Metaiodobenzylguanidine and <sup>18</sup>F-DopamineDavid S Goldstein
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 13, 2025
Peripheral catecholamine systems: an evolutionary perspectiveDavid S Goldstein
Journal of Neural Transmission (Vienna, Austria : 1996)|December 7, 2019
The catecholaldehyde hypothesis: where MAO fits inDavid S Goldstein
Stress (Amsterdam, Netherlands)|May 7, 2020
"Sick-but-not-dead": multiple paths to catecholamine deficiency in Lewy body diseasesDavid S Goldstein
International Journal of Molecular Sciences|July 2, 2021
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not KnowDavid S Goldstein
Cellular and Molecular Neurobiology|November 10, 2010
Adrenal responses to stressDavid S Goldstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 29, 2010
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin systemDavid S Goldstein
Pageof 30

Showing results (21-30 of 291) with videos related to

Sort By:
Pageof 30
Handbook of Clinical Neurology|October 8, 2013
Sympathetic neuroimagingDavid S Goldstein
Heart Rhythm|December 14, 2020
The possible association between COVID-19 and postural tachycardia syndromeDavid S Goldstein
JACC. Cardiovascular Imaging|November 14, 2016
Cardiac Dysautonomia and Survival in Hereditary Transthyretin AmyloidosisDavid S Goldstein
Movement Disorders Clinical Practice|July 6, 2026
Cardiac Sympathetic Neuroimaging in Autonomic Synucleinopathies: <sup>123</sup>I-Metaiodobenzylguanidine and <sup>18</sup>F-DopamineDavid S Goldstein
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 13, 2025
Peripheral catecholamine systems: an evolutionary perspectiveDavid S Goldstein
Journal of Neural Transmission (Vienna, Austria : 1996)|December 7, 2019
The catecholaldehyde hypothesis: where MAO fits inDavid S Goldstein
Stress (Amsterdam, Netherlands)|May 7, 2020
"Sick-but-not-dead": multiple paths to catecholamine deficiency in Lewy body diseasesDavid S Goldstein
International Journal of Molecular Sciences|July 2, 2021
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not KnowDavid S Goldstein
Cellular and Molecular Neurobiology|November 10, 2010
Adrenal responses to stressDavid S Goldstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 29, 2010
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin systemDavid S Goldstein
Pageof 30